Hydrophobic IOL outcomes
Good visual outcomes with new heparin-coated IOL.
Roibeard O’hEineachain
Published: Saturday, April 1, 2017
The prospective randomised controlled trial involved 64 eyes of 32 cataract patients who underwent implantation of either the CT LUCIA 601PY or SN60WF IOL between June 2014 and October 2015However, he noted that the new lens performed less well than the AcrySof lens in terms of PCO. At 12 months, only around half as many eyes were PCO-free in the CT LUCIA group as in the SN60WF group and three patients with the new lens required a YAG capsulotomy. However, he added that the design of the CT LUCIA lens has been modified since the trial and now has a sharper optic edge, which should reduce the incidence of the complication in the future. Regarding glistenings, he noted that all of the new Zeiss IOLs at his centre remained glistening-free at one year, whereas glistenings were present in 13 of the older Alcon lenses. There were, however, some glistenings reported in the new lenses in a large multicentre trial, he said. Tobias Brockmann: tobias.brockmann@charite.de
Tags: heparin coated iol
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Piecing Together a Solution
What is the best use of robotics and AI in cataract and refractive surgery?
Advances in Toric IOL Alignment
Biomorphometric approaches offer high precision and increase efficiency.
Library of Short Videos Complements Educational Offerings
Tackling Waste in Retinal Surgery
Reducing waste from intravitreal injections is an achievable goal.
The Modern Era of Refractive Surgery
New technologies for screening and treatment qualify more patients for intervention.
Monofocal Plus Finding the Balance
Enhanced monofocals may be the future standard of care in cataract patients.
Growing Options Optimise Outcomes in Cataract Surgery
Understanding the promise and potential problems of AI-based IOL formulas.